Skip to content

Public FDA record

Z-1637-2020: BD WAVELINQ 4F EndoAVF System, Arterial Catheter 50 cm, Venous Catheter 43 cm, Sterile EO, Rx only, Mfr.

Recall record Z-1637-2020 for Bard Peripheral Vascular Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1637-2020
Company in FDA record
Bard Peripheral Vascular Inc
FDA record creation date
Apr 2, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The firm has become aware of a potential problem with their venous and arterial magnetic catheters may be at risk of experiencing a magnetic deficiency, which may result in the magnets failing to attract to one another. This may result in procedural delay in obtaining or creating a functional fistula and need for additional contrast to perform the necessary fluoroscopy. This can pose an incremental risk of harm to a diabetic patient's kidney function.

Source facts

Action
On 04/12/2019, the firm sent an "Urgent Medical Device Recall Notification" to its customers to inform them the firm has become aware that the WavelinQ 4FEndoAVF System, Product Code W04200, Lot Number S0053 may be at risk of experiencing a magnetic deficiency between the venous and arterial magnetic catheters, which may result in the magnets failing to attract to one another. The firm is instructing customers to remove any affected inventory from use and provided instructions to its customers to take regarding this product. The firm is requesting its customers to complete the required actions and fill out the Recall and Effectiveness Check Form to confirm the quantities and lot numbers of each recalled products intended to be returned. Email the completed Recall and Effectiveness Check Form to BPV.CustomerSupportCenter@crbard.com or fax it to BPV at 1-800-994-6772. For additional questions, customers are instructed to call the BPV Customer Support Center at 1-800-321-4254 Option #5. On 04/26/2019, a second communication "Urgent Medical Device Recall Notification" letter was sent to each of the US consignees via FedEx with proof of delivery notification. The letter explained the firm's records showing the customer purchased one or more units from the affected lot. The 2nd notice was send to confirm receipt of this recall information. Firm's records indicated they have not received all returned inventory from the customer. The firm's corrective action plan is still being developed. A field action is also in process of being initiated for affected lot of an equivalent product sold outside the US (EverlinQ 4F EndoAVF System). The equivalent product is not approved or sold in the US.
Initiated
2019-04-12
Root cause
Nonconforming Material/Component
Terminated
2021-07-28
Distribution
US Nationwide distribution in the states of NY, TN, TX, FL, NC, GA, NH, MO, CA, SC, AL, IL, VA, IN. No US Gov. Consignees No OUS Consignees for the WavelinQ 4F EndoAVF System. However, a field action is in process of being initiated for affected lot of an equivalent product sold outside the US (EverlinQ 4F EndoAVF System). The equivalent product is not approved or sold in the US.
Recall number
Z-1637-2020
Recall status
Terminated
CDRH record ID
179704
FDA record created
2020-04-02
Recall event number
84946

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗